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Introduction
Myxoid leiomyosarcoma is an unusual variant of leiomyosarcoma.1-3
This type of tumor rarely arises in the abdominal cavity 1 and when
found in this location, the origin is usually the uterus.4 No reports
of primary omental myxoid leiomyosarcoma were found from a
search of the PubMed database. The tumor cells appear well differ-
entiated into smooth muscle cells, exhibit relatively little atypia,5
have abundant myxoid matrix, and a low-grade appearance with
relatively few mitotic figures; however, the prognosis is unfavor-
able.1，6 We describe a rare case of primary myxoid leiomyosarcoma
that originated in the omentum.
Case report
A 41-year-old Japanese woman presented with right lower ab-
dominal pain. Uterine myoma was tentatively diagnosed on
ultrasonography and magnetic resonance imaging (MRI), and the
patient was referred to our hospital for further examination. The
personal and family history were unremarkable.
MRI revealed a 4 cm intramural uterine myoma, and a 7 × 7
× 6 cm mass with a smooth margin was located adjacent to the
anterior surface of the uterus. The latter mass was slightly
hyperintense on T1-weighted images (Figure.1A) and strongly
hyperintense on T2-weighted images (Figure.1B). T1-weighted
post-contrast images showed peripheral enhancement at the
anterio-inferior part of the mass (Figure.1C). Uterine subserosal
myoma with myxoid change was suspected from these findings.
Since the tumor had enlarged to 11 × 10 × 7 cm in 2 months
on follow-up MRI, malignant potential was suspected and the
tumor was resected surgically 2 months after the MRI.
Bloody serous abdominal fluid (1,470 ml) was found during sur-
gery. Cytodiagnosis of the fluid suggested malignancy. A 30 × 20
× 10 cm, pale yellow to white myxoid mass was found in the
greater omentum comprising a cystic gelatinous area and an 8-cm
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A 41-year-old Japanese woman who presented with right lower abdominal pain underwent partial omental resection with tumor exci-
sion, leaving no residual tumor. The tumor was diagnosed as a myxoid leiomyosarcoma that apparently originated in the greater omentum.
A recurrent omental tumor was excised at 4.5 months after the first operation, and then at 5.5 months after this, CT revealed
metastatic sarcoma at the surface of the liver (S7) and the left upper abdomen. She died 20 months after the last operation despite
treatment of the metastases with MAID therapy (mesna, adriamycin, ifosfamide, dacarbazine).
A literature review revealed that this tumor mainly occurs in the uterus, soft tissue, and cardiovascular system, with a preponderance
among middle-aged to elderly women. The present report is the first description of primary omental myxoid leiomyosarcoma.
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soft solid area (Figure.2). It resembled both peritoneal pseudomyxoma
and leiomyosarcoma. The tumor was partially ruptured and the ge-
latinous matrix was exposed to the omental surface. The uterus it-
self was unremarkable except for a 3-cm intramural myoma. The
mesentery of the stomach and transverse colon were not involved.
The tumor was completely excised with partial omental resection.
On histopathological examination, the tumor comprised an ex-
tensive myxoid matrix. Spindle-shaped tumor cells with minimal
atypia and an eosinophilic cytoplasm proliferated in ill-defined
bundles or in interlacing patterns (Figure.3). Many vacuoles were
present in the cytoplasm. There were up to 17 mitoses per 10 high
power fields (HPF).
Immunohistochemical staining was positive for SM actin,
HHF-35 (focal), and vimentin, and negative for desmin, HBME-1,
calretinin, 1 antitrypsin, S-100, CD34, and c-kit. The lesion was
thus diagnosed as myxoid leiomyosarcoma.
At 1 month after the first surgery, follow-up abdominal CT re-
vealed a 2.5 cm low density omental mass that subsequently en-
larged to 3.2 cm within 2.5 months. The omental mass was
resected and histopathologic examination confirmed that it was a
recurrence of the previous tumor.
At 5.5 months after the second surgery, CT revealed peritoneal
dissemination at the surface of the liver (Figure.4) and the left
upper abdomen.
Although the patient was treated with MAID therapy (mesna,
adriamycin, ifosfamide, and dacarbazine) for the metastases, she
died 20 months after the last operation.
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Figure 1. Magnetic resonance imaging findings of the omental tumor
A mass located adjacent to the anterior surface of uterus (*) shows slight
hyperintensity on a T1-weighted image (1A) and strong hyperintensity on
a T2-weighted image (1B). A T1-weighted post-contrast enhanced image
shows peripheral enhancement at the anteroinferior part of the mass (1C).
Figure 2. Gross findings of the omental tumor
A 30× 20 × 10 cm, pale yellow to white myxoid mass is visible in the greater
omentum comprising a cystic gelatinous area (*) and an 8-cm soft solid area
(▲). It resembles both peritoneal pseudomyxoma and leiomyosarcoma. The
tumor is partially ruptured and gelatinous matrix is exposed to the omental
surface (arrows).
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Figure 3. Pathological findings of the tumor
A. Tumor proliferation in an ill-defined interlacing pattern with abundant myxoid matrix (HE ×40).
B. Spindle cells are floating in a slightly basophilic to slightly eosinophilic myxoid matrix. There are areas
of low (left upper area) and high (right lower area) cellularity (HE ×100).
C. High magnification of a highly cellular area. Spindle-shaped cells with narrow eosinophilic cytoplasm
proliferate in a fascicular pattern. There is a mitosis at the center (HE ×400).
D. Tumor cells are immunohistochemically positive for a SM actin (×200).
Figure 4. Computed tomography at recurrence, 5.5 months after second surgery
Peritoneal dissemination at the surface of the liver (A, arrowheads) and the left upper abdomen (B, *).
Chieko Taneda et al.: Primary Omental Myxoid Leiomyosarcoma
Discussion
Myxoid leiomyosarcoma is extremely unusual1-3 and rarely oc-
curs or disseminates in the abdominal cavity.1 Our search of the
PubMed database and the Japanese literature revealed only 94 re-
ports of myxoid leiomyosarcoma. Among these, 41 originated in
the uterus, 28 in soft tissue, 7 in the cardiovascular system, 4 in the
ovary, 4 in the stomach, 2 in the liver, 2 in the esophagus, 2 in the
prostate, and 1 each in the lung, kidney, parotid, and urinary blad-
der. The age ranged from 16 to 88 years (mean 52.7 years), and the
male: female ratio was 15:79 (excluding female-specific organs
such as the uterus and ovaries, M:F = 15:34). When limited to
women, the age ranged from 20 to 85 years (mean 51.6 years). To
the best of our knowledge, primary omental myxoid leiomyosarcoma
has not been previously described; the present report appears to be
the first such case.
Pathologically, the tumor cells had abundant myxoid matrix, and
cellular features with smooth-muscle differentiation. The patho-
genesis of myxoid change has not been established. One previous
study indicates that such tumors are less atypical and have fewer
mitotic figures (0-2/10HPF) than conventional leiomyosarcoma.6
However, contrary to the rather bland appearance, the reported
prognosis of patients with this type of tumor is unfavorable.1,6 King
et al. concluded that since 4 of their 6 patients died of the tumor,
it must be considered fully malignant.6 They also speculated that
spillage of the grossly gelatinous matrix at the time of surgery
might contribute to the common phenomenon of local recurrence.6
The tumor had already ruptured before our patient underwent sur-
gery, which must have led to dissemination and multiple recur-
rences. The myxoid matrix in the abdominal cavity must not be ex-
posed during surgery. In addition, the high mitotic count of up to
17/ 10HPF might have been another reason for the poor outcome.
Differential diagnoses include myxoid endometrial stromal sar-
coma, myxoid leiomyoma, low-grade myxofibrosarcoma,2 nerve
sheath neoplasm,5 and mesothelioma. Immunohistochemical stain-
ing was important for our patient, since the results for smooth mus-
cle were positive and those for nerve sheath neoplasm, histiocytes,
and mesothelial differentiation were negative.
A treatment strategy for myxoid leiomyosarcoma has not yet
been established,7 and surgery has mostly been the first line of
treatment.4,7,8,9 We administered MAID therapy, which has been es-
tablished for treating sarcoma in soft tissue,10 and the patient has
survived on this regimen for 20 months.
We described a rare case of primary myxoid leiomyosarcoma
that originated in the omentum. The tumor gave rise to multiple
metastases, and the patient died despite MAID therapy.
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